RNA
Atrium Therapeutics, Inc.
8.40$
+1.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 12 | Q3 12 | Q4 12 | Q1 13 | Q2 13 | Q3 13 | Q4 13 | Q1 14 | Q2 14 | Q3 14 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 270.6% | 186.5% | 219.0% | 231.2% | 311.9% | 205.0% | 260.5% | 49.3% | 6,584.8% | – | – | 1,130.8% | 784.5% | 390.7% | 408.2% | 583.0% | 541.5% | 635.8% | 764.7% | 871.0% | 1,148.0% | 1,780.1% | 1,542.5% | 1,826.9% | 1,503.5% | 1,647.2% | 2,139.1% | 1,842.5% | 1,693.2% | 28.0% | 18.1% | 33.6% | 30.4% | 24.8% | – | 3,590.5% | – | 174.2% | 0.8% | 11.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -1,030.8% | -684.5% | -290.7% | 100.0% | 100.0% | -441.5% | -535.8% | -664.7% | -771.0% | -1,048.0% | -1,680.1% | -1,442.5% | -1,726.9% | -1,403.5% | -1,547.2% | -2,039.1% | -1,742.5% | -1,593.2% | 72.0% | 81.9% | 66.4% | 100.0% | 100.0% | 100.0% | -3,490.5% | 100.0% | 100.0% | 99.2% | 88.6% | 98.6% | |
| 220.5% | 159.6% | 182.0% | 169.1% | 224.5% | 192.0% | 196.0% | 35.1% | 4,595.7% | – | – | 1,130.8% | 784.5% | 390.7% | 408.2% | 583.0% | 541.5% | 635.8% | 764.7% | 871.0% | 1,148.0% | 1,780.1% | 1,542.5% | 1,826.9% | 1,503.5% | 1,647.2% | 2,139.1% | 1,842.5% | 1,693.2% | 2,408.4% | 1,886.3% | 3,126.7% | 3,304.7% | 3,216.4% | 6,324.9% | 3,590.5% | 1,242.1% | 2,153.3% | 84.8% | 510.8% | 571.1% | |
| – | – | – | – | – | – | – | – | – | – | – | 712.5% | 116.5% | 127.8% | 144.6% | 189.8% | 215.2% | 224.8% | 217.6% | 240.4% | 305.7% | 401.2% | 477.3% | 398.9% | 406.7% | 375.0% | 540.3% | 530.1% | 487.2% | 735.0% | 392.3% | 1,013.7% | 996.3% | 953.2% | 2,136.0% | 958.3% | 46.3% | 3,538.6% | 103.2% | 342.2% | 185.4% | |
| – | – | – | – | – | – | – | – | – | – | – | 1,843.3% | 900.9% | 518.5% | 552.9% | 772.8% | 215.2% | 224.8% | 217.6% | 240.4% | 305.7% | 401.2% | 477.3% | 398.9% | 406.7% | 375.0% | 540.3% | 530.1% | 487.2% | 3,115.4% | 2,260.5% | 4,106.8% | 4,300.9% | 4,169.6% | 8,460.9% | 958.3% | 67.8% | 5,692.0% | 187.2% | 841.5% | 331.9% | |
| – | – | – | – | – | – | – | 48.6% | – | – | – | -1,743.3% | -800.9% | -418.5% | -452.9% | -672.8% | -656.7% | -760.6% | -882.3% | -1,011.4% | -1,353.7% | -2,081.4% | -1,919.8% | -2,125.8% | -1,810.2% | -1,922.2% | -2,579.3% | -2,272.6% | -2,080.4% | -3,043.5% | -2,178.6% | -4,040.4% | -4,200.9% | -4,069.6% | -8,360.9% | -4,448.7% | -67.8% | -5,592.0% | -88.0% | -752.9% | -268.0% | |
| 11.9% | 4.4% | 1.4% | 7.8% | 10.4% | 7.0% | 3.7% | 1.6% | 200.6% | – | – | 542.4% | 224.9% | 300.2% | 5.7% | 8.5% | 0.0% | 19.5% | 0.0% | 0.0% | 0.0% | 0.5% | 13.9% | 28.1% | 54.1% | 79.6% | 17.5% | – | – | 17.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 48.6% | – | – | – | -2,283.9% | -1,025.8% | -719.8% | -448.1% | -685.0% | -655.2% | -759.8% | -881.8% | -1,010.9% | -1,353.4% | -2,080.9% | -1,907.2% | -2,097.8% | -1,756.6% | -1,822.7% | -2,346.4% | -2,030.4% | -1,858.0% | -2,756.2% | -1,943.4% | -3,461.8% | -3,441.7% | -3,439.5% | -7,360.0% | -4,089.3% | -67.8% | -5,592.0% | -84.7% | -672.0% | -259.4% | |
| – | – | – | – | – | – | – | – | – | – | – | 540.6% | 224.9% | 301.3% | -4.8% | 12.2% | -1.5% | -0.8% | -0.5% | -0.5% | -0.3% | -0.5% | -12.5% | -28.1% | -53.6% | -99.5% | -233.0% | -249.2% | -222.9% | 0.0% | 16.9% | – | – | – | – | – | -1.4% | 4.0% | – | – | – | |
| – | – | – | – | – | – | – | 48.6% | – | – | – | -2,283.9% | -1,025.8% | -719.8% | -448.1% | -685.0% | -655.2% | -759.8% | -881.8% | -1,010.9% | -1,353.4% | -2,080.9% | -1,907.2% | -2,097.8% | -1,756.6% | -1,822.7% | -2,346.4% | -2,030.4% | -1,858.0% | -2,756.2% | -1,943.4% | -3,461.8% | -3,441.7% | -3,439.5% | -7,360.0% | -4,089.3% | -66.4% | -5,595.9% | -84.7% | -672.0% | -259.0% | |
| – | – | – | – | – | – | – | – | – | – | – | -1,704.0% | -788.0% | -413.8% | -436.2% | -671.7% | -650.9% | -755.3% | -878.3% | -1,005.8% | -1,345.5% | -2,070.1% | -1,902.3% | -2,111.0% | -1,795.3% | -1,908.4% | -2,561.8% | -2,249.8% | -2,060.3% | -3,015.4% | -2,160.5% | -4,006.8% | -4,170.5% | -4,044.8% | -8,311.0% | -4,427.6% | -67.3% | -5,577.8% | -83.9% | -741.5% | -264.3% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.